drugset / Trial / NCT02335151

CTC Pancreatic Adenocarcinoma

NCT02335151

RandomizedParallel-groupDouble-blindTreatment

Summary

Proportion of circulating tumor cells (CTC) in the postoperative phase after curative tumor removal of pancreatic cancer will be determined and correlated to the accordance of anesthesia (desflurane versus propofol)

Timeline

Start
2016-10
Primary completion
2019-09
Completion
2019-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Desflurane Other / unclassified